Capital City Bank Group, Inc. Announces Quarterly Dividend
/
Date22 Feb 2017
TALLAHASSEE, Fla., Feb. 22, 2017 (GLOBE NEWSWIRE) — The Board of Directors of Capital City Bank Group, Inc. (Nasdaq:CCBG) declared a quarterly cash dividend on... Read More →
Genesis HealthCare Reports Fourth Quarter and Fiscal Year End 2016 Results
/
Date22 Feb 2017
KENNETT SQUARE, Pa., Feb. 22, 2017 (GLOBE NEWSWIRE) — Genesis HealthCare (Genesis, or the Company) (NYSE:GEN), one of the largest post-acute care providers in the... Read More →
Brady Corporation declares regular dividend to shareholders
/
Date22 Feb 2017
MILWAUKEE, Feb. 22, 2017 (GLOBE NEWSWIRE) — On February 22, 2017, Brady Corporation’s (NYSE:BRC) Board of Directors declared a quarterly dividend to shareholders of the... Read More →
ATN Reports Fourth Quarter and Full Year 2016 Results
/
Date22 Feb 2017
Fourth Quarter Financial Highlights: Revenues: $128.5 million Adjusted EBITDA1: $34.1 million Operating income: $10.9 million Net income attributable to ATN’s stockholders: $2.3 million, or $0.14... Read More →
CNL Healthcare Properties II Signs Agreement for First Acquisition
/
Date22 Feb 2017
Summer Vista exterior Exterior of Summer Vista Assisted Living CNL Healthcare Properties II Summer Vista interior 1 Interior shot of Summer Vista assisted living Summer... Read More →
Achaogen Announces Achievement of a Key Milestone in Developing a Plazomicin Assay to Support Therapeutic Drug Management (TDM)
/
Date22 Feb 2017
Strategic milestone achieved in TDM assay development Thermo Fisher Scientific to develop and then commercialize its assay for measuring the concentration of plazomicin SOUTH SAN... Read More →
Lincoln Electric Board Declares Dividend
/
Date22 Feb 2017
CLEVELAND, Feb. 22, 2017 (GLOBE NEWSWIRE) — Lincoln Electric Holdings, Inc., (Nasdaq:LECO) announced today that its Board of Directors has declared a quarterly cash dividend... Read More →
SP Plus Corporation Announces Fourth Quarter and Full-Year 2016 Results
/
Date22 Feb 2017
SP Plus Corporation Announces Fourth Quarter and Full-Year 2016 Results
Bellicum Presents Updated Clinical Results at 2017 BMT Tandem Meetings on BPX-501 in Orphan Inherited Blood Disorders and Hematologic Cancers
/
Date22 Feb 2017
HOUSTON, Feb. 22, 2017 (GLOBE NEWSWIRE) — Bellicum Pharmaceuticals, Inc. (Nasdaq:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood... Read More →
First Capital, Inc. Announces Quarterly Dividend
/
Date22 Feb 2017
CORYDON, Ind., Feb. 22, 2017 (GLOBE NEWSWIRE) — The Board of Directors of First Capital, Inc. (NASDAQ:FCAP) has declared a quarterly cash dividend of $0.21... Read More →